Medtronic has recently notified the public that it received a warning letter from the FDA over quality control concerns at its diabetes unit. Included within that letter were issues related to the corporation’s risk assessment, its propensity for device recalls, and the way it handles complaints that are brought to its attention. News of the letter sent Medtronic’s stock price down to some of its lowest ...
Medtronic’s Diabetes Unit Gets a Warning Letter from the FDA
Posted January 18, 2022 in Drug and Medical Device Lawsuits | Product News and Recalls
A Tidal Wave Builds as Insulin Pricing Outrage Grows
Posted March 18, 2019 in Drug and Medical Device Lawsuits | Product News and Recalls
There is no way to overstate the importance of the discovery of insulin and the impact it has had on the world. Insulin has either extended or saved the lives of countless diabetics in the nearly 100 years since the discovery occurred. While the event and the attention it would bring would lead to significant strains on the interpersonal relationships of those involved, the researchers nonetheless ...
